FindMyKOL
Clinical trialNCT03705416Active, not recruitingObservational

Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy

NCT03705416 is an observational study sponsored by Johns Hopkins University. As of 21 Nov 2026, it is active and no longer recruiting. It studies GERD and Obesity. The registry lists an enrollment of 250 participants at 6 sites in 1 country. The registry lists a start date of 30 Mar 2019 and a primary completion date of 31 Dec 2026.

SponsorJohns Hopkins University →Enrollment250GERDObesity
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03705416
FieldValue
Registry IDNCT03705416
StatusActive not recruiting
Study typeObservational study
Lead sponsorJohns Hopkins University
Enrollment250
Registered sites6
Countries1
ConditionsGERD and Obesity
Start30 Mar 2019
Primary completion31 Dec 2026
Study completion30 Mar 2028
Last update posted21 Aug 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

GERD is common in the obese population. Bariatric procedures are the mainstay of therapy for these patients. Bariatric procedures can be surgical (Roux-en-Y gastric bypass and Vertical sleeve gastrectomy) or endoscopic (endoscopic sleeve gastroplasty). The rate of GERD after either treatment is unknown as is the rate of silent reflux. The study primary objective is to assess the incidence rate of GERD in bariatric patients that undergo either therapy.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Maryland, United States1 site
  • Johns Hopkins University

    Baltimore

New York, United States2 sites
  • Northwell Health

    New Hyde Park

  • Weill Cornell

    New York

Oregon, United States1 site
  • Legacy Oregon Clinic

    Portland

Texas, United States1 site
  • Memorial Hermann Health System

    Houston

Utah, United States1 site
  • Utah-Health: University of Utah

    Salt Lake City

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 2 sitesNY2MassachusettsMARhode IslandRIOregon: 1 siteOR1IdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 1 siteMD1DelawareDEArizonaAZUtah: 1 siteUT1ColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03705416

Each answer restates registry values shown on this page.

What is NCT03705416?

NCT03705416 is an observational study sponsored by Johns Hopkins University. It studies GERD and Obesity.

Is NCT03705416 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT03705416?

The registry names Marcia I Canto, MD (principal investigator, Johns Hopkins University) as the overall official.

Where does NCT03705416 run?

The registry lists 6 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT03705416 expected to complete?

The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 30 Mar 2028. The sponsor last updated the record on 21 Aug 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.